Hemorrhagic Occlusive Retinal Vasculitis and Intravitreal Anti-VEGF
Prithvi Ramtohul, Mathieu Chanal, Thierry David
原始摘要（英文原文）· Original abstract
This case report discusses bilateral vision loss 2 weeks after second bilateral intravitreal injection of the anti–vascular endothelial growth factor (VEGF) brolucizumab for diabetic macular edema in a woman in her 60s.